TP53-Mutant Clonal Hematopoiesis Marks a High-Risk CAR-T Subgroup

Consortium: LMU-Led Research Team · Finding: TP53-Mutant Clonal Hematopoiesis · Setting: CD19/BCMA CAR-T Recipients · Publication: Leukemia · Date: August 24, 2026 Summary A single-center study of 104 recipients of commercial CD19- or BCMA-directed CAR-T found that overall clonal hematopoiesis (CHIP) was not associated with…